Before the Open (Sep 13)

Good morning. Happy Thursday.
The Asian/Pacific markets closed mostly up. Japan, China, Hong Kong, India, New Zealand, Indonesia, Thailand and the Philippines did very well; Australia was weak. Europe, Africa and the Middle East currently lean to the upside. Poland, Turkey, Russia, Finland and Spain are leading; the UAE, Greece and Saudi Arabia are weak. Futures in the States point towards a moderate gap up open for the cash market.
—————
VIDEO: Trading ZUO, ZS and DOCU with Multiple Time Frames and Technical Indicators
—————
The dollar is up. Oil is down; copper is up. Gold and silver are unchanged. Bonds are down.
Overnight Stock Movers from barchart.com…
Qualcomm (QCOM -1.05%) was reinstated at Barclays with an ‘Overweight’ rating and a price target of $95.
DaVita (DVA +1.50%) was upgraded to ‘Neutral’ from ‘Underweight’ at JPMorgan Chase with a price target of $68.
Rocket Pharmaceuticals (RCKT -2.44%) was rated a new ‘Buy’ at Ladenburg Thalmann & Co with a price target of $30.
Oxford Industries (OXM -0.70%) slid more than 3% in after-hours trading after it forecast Q3 net sales of $235 million to $245 million, weaker than consensus of $246.7 million.
Tailored Brands (TLRD +1.48%) rose more than 4% in after-hours trading after it said Q2 custom sales doubled versus last year with sales averaging $4 million per week.
Floor & Decor Holdings (FND +1.99%) lost 1% in after-hours trading after it announced that funds affiliated with Ares Management L.P. and Freeman Spogli Management L.P. intend to offer for sale an underwritten secondary offering of 10 million shares of Floor & Decor common stock.
Brady Corp (BRC +0.48%) boosted its quarterly dividend to $0.2125 a share from $0.2075, higher than expectations of $0.21.
SemGroup (SEMG +0.21%) lost 2% in after-hours trading after it announced that ten holders of its stock were selling a total of 1.2 million shares between $23.70 and $23.75 a share.
Aquestive Therapeutics (AQST +1.04%) was rated a new ‘Outperform’ at Wedbush with a price target of $33.
Sensus Healthcare (SRTS -4.37%) dropped 6% in after-hours trading after it announced that it had commenced a public offering of its common stock. although no size was given.
Impinj (PI +1.13%) rallied 15% in after-hours trading after it reported a Q2 adjusted loss of -19 cents per share, narrower than consensus of -31 cents, and then forecast a Q3 adjusted loss per share of -12 cents to -17 cents, a smaller loss than consensus of -26 cents.
Progenics (PGNX -1.62%) tumbled 16% in after-hours trading after it said the co-primary endpoint in a Phase 3 trial of its Imaging Agent 1404 was not met in detecting clinically meaningful prostate cancer.
Foamix Pharmaceuticals Ltd (FOMX +3.21%) fell almost 3% in after-hours trading after it announced that it intends to offer $70 million of its ordinary shares in an underwritten public offering.
Today’s Economic Calendar
8:30 Initial Jobless Claims
8:30 Consumer Price Index
10:30 EIA Natural Gas Inventory
12:30 PM Fed’s Bostic: Economic Outlook and Monetary Policy
1:00 PM Results of $15B, 30-Year Note Auction
2:00 PM Treasury Budget
4:30 PM Money Supply
4:30 PM Fed Balance Sheet
Other…
today’s upgrades/downgrades from briefing.com
this week’s Earnings from Morningstar
this week’s Economic Numbers/Reports powered by ECONODAY